Logo of the Biotechnology Industry Organization. (Photo credit: Wikipedia)I believe one of the keys to smart biotech investing is to focus on companies that are treating chronic diseases. Instead of looking to cure something, the treatments developed and marketed by these companies will help patients manage symptoms. This ensures long-term success and allows you to invest your money in a company that is protecting its own security. There are five standout companies in the biotech industry that I consider the best bets for those who want a long term, steady earner.
The first company I have been watching for awhile is Human Genome Sciences (HGSI). The company is poised to make a big splash in 2012, due to its focus on treatments that will affect the baby boomer generation. The company reached a 52-week high of $30 per share at one point, but plummeted to just $6 per share in the last year. The price is currently around... Continue to read.
No comments:
Post a Comment